THE VALUE OF 1.5 TESLA MAGNETIC RESONANCE IMAGING IN PREOPERATIVE Tis, T1, T2 STAGING OF GLOTTIC CANCER
Main Article Content
Abstract
Objective: This study aims to evaluate the value of 1.5 Tesla Magnetic Resonance Imaging (MRI) in assessing the invasion of submucosal structures (anterior commissure, paraglottic space, thyroid cartilage, supraglottis, and subglottis) and in staging T classification in 35 patients with early-stage glottic cancer (Tis, T1, T2). Subjects and Methods: A retrospective cross-sectional study was conducted on 35 patients with early-stage glottic cancer who underwent MRI and surgery at Hanoi Oncology Hospital from January 2022 to February 2025. MRI and histopathological results were analyzed to assess tumor location, invasion extent, and T staging. Results: The average age of the patients was 63.46 ± 7.13 years, with 100% being male, 97.1% having a history of smoking, and 85.7% having a history of alcohol consumption. The most common symptom was hoarseness (91.4%). 80% of tumors were unilateral (32.3% in the left vocal cord, 38.7% in the right vocal cord). Compared to histopathology, MRI tended to overestimate the invasion of submucosal structures, with the highest overestimation occurring at the anterior commissure (34.3% vs. 28.6%). However, MRI still demonstrated high accuracy in T classification, correctly staging 82.9% of cases (95% confidence interval: 66–93%). Additionally, there was a strong correlation, with a correlation coefficient of tau-b = 0.75 according to Kendall’s tau-b and rho = 0.77 according to Spearman’s rho. Conclusion: MRI has high accuracy in assessing submucosal invasion and T staging of early-stage glottic cancer (Tis, T1, T2).
Article Details
Keywords
Early-stage glottic cancer, MRI
References

2. Nocini R, Molteni G, Mattiuzzi C, Lippi G. Updates on larynx cancer epidemiology. Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu. 2020;32(1): 18-25. doi:10.21147/j.issn.1000-9604.2020.01.03


3. Edge SB, American Joint Committee on Cancer, eds. AJCC Cancer Staging Manual. 7th ed. Springer; 2010.

4. Arboleda LPA, Neves AB, Kohler HF, et al. Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer Rep. 2023;6(8): e1837. doi:10.1002/cnr2.1837


5. Becker M, Zbären P, Casselman JW, Kohler R, Dulguerov P, Becker CD. Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging. Radiology. 2008;249(2):551-559. doi:10.1148/radiol.2492072183


6. Jones J, V VN, Sebastian S, et al. Outcome of Patients with Early Glottic Laryngeal Carcinoma Treated with Radical Radiotherapy. Asian Pac J Cancer Care. 2024;9(3):475-480. doi:10.31557/ apjcc.2024.9.3.475-480


7. Wu JH, Zhao J, Li ZH, et al. Comparison of CT and MRI in Diagnosis of Laryngeal Carcinoma with Anterior Vocal Commissure Involvement. Sci Rep. 2016;6:30353-30353. doi:10.1038/srep30353


8. Liberale C, Soloperto D, Marchioni A, Monzani D, Sacchetto L. Updates on Larynx Cancer: Risk Factors and Oncogenesis. Int J Mol Sci. 2023;24(16): 12913. doi:10.3390/ ijms241612913


9. Allegra E, Ferrise P, Trapasso S, et al. Early Glottic Cancer: Role of MRI in the Preoperative Staging. BioMed Res Int. 2014;2014:890385. doi:10.1155/2014/890385


10. Williamson AJ, Bondje S. Glottic Cancer. In: StatPearls. StatPearls Publishing; 2025. Accessed March 6, 2025. http://www.ncbi.nlm.nih.gov/ books/NBK558979/
